- Investing Ideas
- /
- Global Inefficient Market Opportunities
Global Inefficient Market Opportunities
UPDATED Apr 21, 2024
Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.
355 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CRPR | UK£2.70 | 1.9% | -61.7% | UK£25.8m | n/a | PE7.9x | E35.9% | 2.6% | Materials | ||
6JC | UK£3.16 | 11.3% | -54.5% | UK£25.8m | n/a | PE7.9x | E35.9% | 2.6% | Materials | ||
DSK | AU$0.80 | -3.0% | -47.0% | AU$49.5m | n/a | PE7.9x | E23.6% | 6.3% | Retail | ||
ECK | €17.45 | -10.5% | -7.7% | €29.9m | €45.50 | PE5.7x | E17.5% | n/a | Utilities | ||
3680 | JP¥290.00 | -3.3% | -8.5% | JP¥4.5b | JP¥2,559.28 | PE20.1x | E80.7% | n/a | Software | ||
P731 | CA$1.03 | -1.9% | 13.8% | CA$40.4m | CA$2.00 | PE5x | E46.9% | n/a | Pharmaceuticals & Biotech | ||
MEDX.F | CA$1.22 | 6.7% | 21.9% | CA$40.4m | CA$2.37 | PE5x | E46.9% | n/a | Pharmaceuticals & Biotech | ||
MDP | CA$1.65 | 5.8% | 19.6% | CA$40.4m | CA$3.21 | PE5x | E46.9% | n/a | Pharmaceuticals & Biotech | ||
NPOLYMER | ৳43.70 | -6.2% | -14.3% | ৳3.2b | ৳71.00 | PE14.5x | E37.0% | 2.4% | Capital Goods | ||
5C2 | R0.26 | 15.8% | 135.7% | R510.6m | n/a | PE2.7x | E12.3% | n/a | Real Estate Management and Development | ||
CGR | R5.70 | 14.0% | 107.3% | R510.6m | R8.00 | PE2.7x | E12.3% | n/a | Real Estate Management and Development | ||
0QM | kr0.31 | -0.9% | 1.6% | kr283.8m | n/a | PE11.6x | E25.0% | 0% | Consumer Services | ||
A1Z1 | UK£0.059 | -5.6% | -15.0% | UK£21.1m | n/a | PE34.8x | E80.6% | n/a | Commercial Services | ||
EAAS | UK£0.06 | -3.2% | -6.5% | UK£21.1m | n/a | PE34.8x | E80.6% | n/a | Commercial Services | ||
1598 | HK$0.18 | 0.6% | -38.6% | HK$203.1m | n/a | PE4.7x | E30.3% | 0% | Consumer Services | ||
5868 | JP¥1,026.00 | -2.7% | n/a | JP¥3.8b | n/a | PE13.1x | E30.5% | 1.9% | Software | ||
ODA | AU$0.20 | 0% | -4.8% | AU$33.8m | n/a | PE22.3x | E51.5% | n/a | Software | ||
ODA | AU$0.20 | -4.8% | 0% | AU$33.8m | n/a | PE22.3x | E51.5% | n/a | Software | ||
O01 | €0.79 | 0% | n/a | €19.7m | €3.75 | PE4.6x | E39.6% | n/a | Retail | ||
PSQ | €0.79 | -2.2% | n/a | €19.7m | €3.75 | PE4.6x | E39.6% | n/a | Retail | ||
G37 | €0.49 | -2.0% | -46.0% | €19.3m | €1.15 | PE4.1x | E33.6% | n/a | Media | ||
IE | €0.54 | -2.2% | -43.4% | €19.3m | €1.25 | PE4.1x | E33.6% | n/a | Media | ||
PLT | ฿0.77 | -3.8% | n/a | ฿739.2m | ฿1.35 | PE16.8x | E38.1% | 15.6% | Energy | ||
PLT-R | ฿0.77 | -3.8% | n/a | ฿739.2m | ฿1.35 | PE16.8x | E38.1% | 15.6% | Energy |